Literature DB >> 11531710

Replacing cardiopulmonary bypass with extracorporeal membrane oxygenation in lung transplantation operations.

W J Ko1, Y S Chen, Y C Lee.   

Abstract

Cardiopulmonary bypass (CPB) is required in some lung transplantation (LTx) operations. However, it increases risks of bleeding and early graft dysfunction. We report our experiences of replacing CPB with heparin-bound extracorporeal membrane oxygenation (ECMO) in LTx operations. If extracorporeal circulation was anticipated for the LTx operations, ECMO support was set up through the femoral venoarterial route after induction of anesthesia; then, LTx was done as usual. Five thousand units of heparin was injected intravenously during the femoral vessels cannulation, but no more was used during the first 24 h of ECMO support. If necessary, as in patients undergoing single LTx for end-stage pulmonary hypertension, the ECMO support was directly extended into the postoperative period until reperfusion edema of the graft lung subsided. Twelve single LTxs and 3 bilateral sequential single LTxs were done under ECMO support. The advantages of using femoral ECMO rather than conventional CPB in LTx operations were the operative field was not disturbed by the bypass cannula, stable cardiopulmonary function and normothermia were maintained throughout the operations, there were less blood loss and transfusion requirements, and the left LTx was as easily performed as the right LTx. Red blood cell transfusion requirements during the operation and the first postoperative day were 4.4 +/- 2.8 and 2.4 +/- 2.0 U, respectively, in 10 adult patients undergoing uncomplicated single LTx with ECMO support, and 4.3 +/- 1.3 and 1.5 +/- 1.5 U in 8 adult patients undergoing single LTx without any extracorporeal circulatory support. The difference was not significant between the 2 groups (p = 0.53 and 0.32 by Mann-Whitney U test). The ECMO did not increase blood transfusion requirements. In comparison, 13 U of red blood cell transfusion was required in 2 patients receiving single LTx under CPB support. The ECMO support made the postoperative critical care easier in recipients with graft lung edema. Except for 2 cases of primary graft failure, the ECMO could be weaned off and removed at bedside within a short period (27.9 +/- 24.6 h, n = 13) with no major complications. In conclusion, the heparin-bound femoral ECMO rather than CPB should be used for LTx operations unless concomitant cardiac repair is planned.

Entities:  

Mesh:

Year:  2001        PMID: 11531710     DOI: 10.1046/j.1525-1594.2001.025008607.x

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  10 in total

Review 1.  Established and potential predictors of blood loss during lung transplant surgery.

Authors:  Pascal Oechslin; Marco P Zalunardo; Ilhan Inci; Martin Schlaepfer; Bastian Grande
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

Review 2.  Lung volume reduction followed by lung transplantation-considerations on selection criteria and outcome.

Authors:  Alexis Slama; Christian Taube; Markus Kamler; Clemens Aigner
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

3.  Short-term outcomes of cadaveric lung transplantation in ventilator-dependent patients.

Authors:  Hsao-Hsun Hsu; Jin-Shing Chen; Wen-Je Ko; Shu-Chien Huang; Shuenn-Wen Kuo; Pei-Ming Huang; Nai-Hsin Chi; Chin-Chih Chang; Robert J Chen; Yung-Chie Lee
Journal:  Crit Care       Date:  2009-08-06       Impact factor: 9.097

Review 4.  Primary graft dysfunction: lessons learned about the first 72 h after lung transplantation.

Authors:  Mary K Porteous; Joshua M Diamond; Jason D Christie
Journal:  Curr Opin Organ Transplant       Date:  2015-10       Impact factor: 2.640

5.  The technique of intraoperative axillary artery cannulation for extracorporeal membrane oxygenation in lung transplantation.

Authors:  Chao Yang; Guilin Peng; Xin Xu; Bing Wei; Hanyu Yang; Jianxing He
Journal:  J Thorac Dis       Date:  2019-07       Impact factor: 2.895

6.  Respiratory failure after lung transplantation: extra-corporeal membrane oxygenation as a rescue treatment.

Authors:  Paulo Manuel Pêgo-Fernandes; Ludhmila Abrahão Hajjar; Filomena Regina Barbosa Gomes Galas; Marcos Naoyuki Samano; Alexandre Kazantzi Fonseca Ribeiro; Marcelo Park; Rodolfo Soares; Eduardo Osawa; Fabio Biscegli Jatene
Journal:  Clinics (Sao Paulo)       Date:  2012-12       Impact factor: 2.365

Review 7.  Perioperative circulatory support for lung transplantation.

Authors:  Akihiro Ohsumi; Hiroshi Date
Journal:  Gen Thorac Cardiovasc Surg       Date:  2021-03-05

8.  A Review of Anesthesia for Lung Transplantation.

Authors:  Hye-Jin Kim; Sang-Wook Shin; Seyeon Park; Hee Young Kim
Journal:  J Chest Surg       Date:  2022-08-05

9.  Plasma concentrations of inflammatory cytokines rise rapidly during ECMO-related SIRS due to the release of preformed stores in the intestine.

Authors:  R Britt McILwain; Joseph G Timpa; Ashish R Kurundkar; David W Holt; David R Kelly; Yolanda E Hartman; Mary Lauren Neel; Rajendra K Karnatak; Robert L Schelonka; G M Anantharamaiah; Cheryl R Killingsworth; Akhil Maheshwari
Journal:  Lab Invest       Date:  2009-11-09       Impact factor: 5.662

Review 10.  Extracorporeal membrane oxygenator as a bridge to successful surgical repair of bronchopleural fistula following bilateral sequential lung transplantation: a case report and review of literature.

Authors:  Nouman U Khan; Mohamed Al-Aloul; Noman Khasati; Ali Machaal; Colm T Leonard; Nizar Yonan
Journal:  J Cardiothorac Surg       Date:  2007-06-05       Impact factor: 1.637

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.